Deep Bio: Demonstrated globally-recognized standards in safety and quality management as a medical software manufacturer SEOUL, SOUTH KOREA (PRWEB) AUGUST 16, 2022 Deep Bio, a pioneer in medical AI for pathologic cancer diagnostics, announced...

[SEOUL, South Korea, Jul. 21, 2022] Lunit, a global provider of AI-powered cancer solutions, announced today that it made its stock market debut on the South Korean KOSDAQ under the ticker “A32813”. Lunit’s initial public offering of...

Small Business Innovation Research Program Seed Funding will Support R&D to Improve Coronavirus Testing Methodology BALTIMORE--(BUSINESS WIRE)--xMD Diagnostics, Inc. has been awarded a National Science Foundation (NSF) Small Business...

Wed, 30th September  |  USA  8am PDT, 11am EDT  |  UK 4pm BST  |  EU 5pm CEST Register Guest Speaker: Will Howat, Ph.D. - Head of Histopathology / ISH Cancer Research UK, Cambridge Institute As more samples are taken...